Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM)

CUSIP: 45257U108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
109,968,942
Total 13F shares
2,790,928
Share change
+418,136
Total reported value
$36,364,000
Put/Call ratio
43%
Price per share
$12.96
Number of holders
28
Value change
+$4,810,967
Number of buys
17
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 45257U108?
CUSIP 45257U108 identifies IMNM - Immunome Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) as of Q4 2021

As of 31 Dec 2021, Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,790,928 shares. The largest 10 holders included Alpine Global Management, LLC, Prentice Capital Management, LP, VANGUARD GROUP INC, Cerity Partners LLC, BANK OF MONTREAL /CAN/, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Atom Investors LP, and BlackRock Inc.. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.